GlassScriptPhysician profile
Marcus O Campbell
NPI 1912567140
$1,441.24
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $820 · 2023: $249 · 2024: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $304.93 | 2022-2023 | Veltassa |
| Horizon Therapeutics Plc | $248.03 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $223.09 | 2021-2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $121.86 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.78 | 2022 | |
| Ardelyx, INC. | $82.49 | 2024 | Xphozah 30 Mg |
| Otsuka America Pharmaceutical, INC. | $69.56 | 2022-2023 | Jynarque |
| Nxstage Medical, INC. | $60.91 | 2022-2023 | Nxstage Cartridge Express, Nxstage System One |
| Akebia Therapeutics INC | $46.25 | 2022 | |
| Mallinckrodt Hospital Products INC. | $38.26 | 2023 | Terlivaz |
| Kyowa Kirin, INC. | $28.58 | 2024 | Crysvita |
| Btg International INC. | $25.24 | 2023 | |
| Calliditas Therapeutics US INC. | $23.19 | 2023 | Tarpeyo |
| Baxter Healthcare | $22.35 | 2024 | Renal - Acute |
| Fresenius USA Marketing, INC. | $18.40 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $17.32 | 2023 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.